פתיחת תפריט נגישות
גישה מהירה לדף הבית

אבנים טיוטה - טיפול טבעי

עודכן בתאריך 27/08/2019
  1. Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Nov 4;161(9):659–67. https://www.ncbi.nlm.nih.gov/pubmed/25364887
  2. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol [Internet]. 1996 Mar;155(3):839–43. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8583588
  3. Di Silverio F, Ricciuti GP, D’Angelo AR, Fraioli A, Simeoni G. Stone recurrence after lithotripsy in patients with recurrent idiopathic calcium urolithiasis: efficacy of treatment with fiuggi water. Eur Urol. 2000 Feb;37(2):145–8. https://www.ncbi.nlm.nih.gov/pubmed/10705191
  4. Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, et al. A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract. 2008;110(3):c185-194. https://www.ncbi.nlm.nih.gov/pubmed/18957869
  5. Hiatt RA, Ettinger B, Caan B, Quesenberry CP, Duncan D, Citron JT. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996 Jul 1;144(1):25–33. https://www.ncbi.nlm.nih.gov/pubmed/8659482
  6. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med [Internet]. 2002 Jan 10;346(2):77–84. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11784873 https://www.nejm.org/doi/full/10.1056/NEJMoa010369#t=article
  7. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med. 2004 Apr 26;164(8):885–91. https://www.ncbi.nlm.nih.gov/pubmed/15111375
  8. Mehta TH, Goldfarb DS. Uric acid stones and hyperuricosuria. Adv Chronic Kidney Dis [Internet]. 2012 Nov;19(6):413–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23089277
  9. Heilberg IP, Goldfarb DS. Optimum nutrition for kidney stone disease. Adv Chronic Kidney Dis [Internet]. 2013 Mar;20(2):165–74. https://www.ncbi.nlm.nih.gov/pubmed/23439376
  10. Rodgers A. Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis. Urol Res. 1999;27(1):77–81 https://www.ncbi.nlm.nih.gov/pubmed/10092157
  11. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996 Sep;156(3):907–9. https://www.ncbi.nlm.nih.gov/pubmed/8709360
  12. Massey LK, Liebman M, Kynast-Gales SA. Ascorbate increases human oxaluria and kidney stone risk. J Nutr. 2005 Jul;135(7):1673–7. https://www.ncbi.nlm.nih.gov/pubmed/15987848
  13. חסר
  14. Trinchieri A. Diet and renal stone formation. Minerva Med. 2013 Feb;104(1):41–54. https://www.ncbi.nlm.nih.gov/pubmed/23392537
  15. Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol [Internet]. 2014 May;29(5):363–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24752465
  16. Carbone A, Al Salhi Y, Tasca A, Palleschi G, Fuschi A, De Nunzio C, et al. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol [Internet]. 2018 Aug;70(4):393–400. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29856171
  17. Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci [Internet]. 1979 Sep;57(3):285–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/573189
  18. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med [Internet]. 1993 Mar 25;328(12):833–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8441427
  19. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med [Internet]. 1997 Apr 1;126(7):497–504. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9092314
  20. Harris SS, Dawson-Hughes B. Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women. J Am Coll Nutr [Internet]. 2015;34(4):340–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25856469
  21. Martini LA, Heilberg IP. Stop dietary calcium restriction in kidney stone-forming patients. Nutr Rev [Internet]. 2002 Jul;60(7 Pt 1):212–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12144200
  22. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59(1):270-276. https://www.ncbi.nlm.nih.gov/pubmed/11135080
  23. Lotfi Yagin N, Mahdavi R, Nikniaz Z. Oxalate content of different drinkable dilutions of tea infusions after different brewing times. Health Promot Perspect [Internet]. 2012;2(2):218–22. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24688937
  24. Massey LK, Palmer RG, Horner HT. Oxalate content of soybean seeds (Glycine max: Leguminosae), soyfoods, and other edible legumes. J Agric Food Chem [Internet]. 2001 Sep;49(9):4262–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11559120
  25. Massey LK. Dietary influences on urinary oxalate and risk of kidney stones. Front Biosci [Internet]. 2003 May 1;8:s584-594. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12700096 https://pdfs.semanticscholar.org/9486/13381a27cf36aB79ff730b13631c3eff4986.pdf
  26. Robertson, W.G., & H. Hughes: Importance of mild hyperoxaluria in the pathogenesis of urolithiasis - new evidence from studies in the Arabian peninsula. Scanning Microscopy Intl. 7:391-402 (1993) https://www.ncbi.nlm.nih.gov/pubmed/8316808
  27. Urivetzky, M., D. Kessaris, & A.D. Smith: Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J.Urol. 147:1215-1218 (1992)https://www.ncbi.nlm.nih.gov/pubmed/1569652
  28. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis [Internet]. 2018 Jun;46(3):265–70. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28674784
  29. Chai W, Liebman M. Assessment of oxalate absorption from almonds and black beans with and without the use of an extrinsic label. J Urol [Internet]. 2004 Sep;172(3):953–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15311007
  30. Liebman, M., & G. Costa: Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J.Urol 163:1565-1569 (2000) https://www.ncbi.nlm.nih.gov/pubmed/10751889
  31. Robertson WG, Peacock M, Heyburn PJ, Hanes FA, Rutherford A, Clementson E, et al. Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol [Internet]. 1979 Dec;51(6):427–31. Available from: https://www.ncbi.nlm.nih.gov/pubmed/534817
  32. Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, et al. Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol [Internet]. 2014 Jul;192(1):137–41. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24518789
  33. Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, et al. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409–13. https://www.ncbi.nlm.nih.gov/pubmed/30566003
  34. Gordiano EA, Tondin LM, Miranda RC de, Baptista DR, Carvalho M. Evaluation of food intake and excretion of metabolites in nephrolithiasis. J Bras Nefrol [Internet]. 2014 Dec;36(4):437–45. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25517271
  35. Marckmann P, Osther P, Pedersen AN, Jespersen B. High-protein diets and renal health. J Ren Nutr [Internet]. 2015 Jan;25(1):1–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25091135
  36. Massey LK, Kynast-Gales SA. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones. J Am Diet Assoc [Internet]. 2001 Mar;101(3):326–31. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11269613
  37. Bleich HL, Moore MJ, Lemann J, Adams ND, Gray RW. Urinary calcium excretion in human beings. N Engl J Med. 1979 Sep 6;301(10):535–41. https://www.ncbi.nlm.nih.gov/pubmed/37442
  38. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982 Sep;22(3):292–6.https://www.ncbi.nlm.nih.gov/pubmed/7176331
  39. Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol [Internet]. 2018 Nov;33(11):1033–47. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30066054
  40. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004 Dec;66(6):2402–10.https://www.ncbi.nlm.nih.gov/pubmed/15569332
  41. Abo-EL-Sooud K, Hashem M, M E Eleiwa M, Q Gab-Allaha A. Antiurolithiatic activity of Edible plants and products. Natural Products : An Indian Journal [NPAIJ]. 2012 Jan 1;8:168–74. https://www.researchgate.net/publication/256457757
  42. Stampfer MJ. Comparison of Dietary Calcium with Supplemental Calcium and Other Nutrients as Factors Affecting the Risk for Kidney Stones in Women. Annals of Internal Medicine, 1997. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.853.1303&rep=rep1&type=pdf
  43. Kessler T, Jansen B, Hesse A. Effect of blackcurrant-, cranberry- and plum juice consumption on risk factors associated with kidney stone formation. European Journal of Clinical Nutrition. 2002 Oct;56(10):1020. https://www.nature.com/articles/1601442
  44. Trinchieri A, Lizzano R, Bernardini P, Nicola M, Pozzoni F, Romano A-L, et al. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Digestive and Liver Disease. 2002 Sep 1;34:S160–3. https://www.sciencedirect.com/science/article/pii/S1590865802801864
  45. Ilbey YO, Ozbek E, Simsek A, Cekmen M, Somay A, Tasci AI. Effects of Pomegranate Juice on Hyperoxaluria-Induced Oxidative Stress in the Rat Kidneys. Renal Failure. 2009 Jan 1;31(6):522–31. https://www.tandfonline.com/doi/full/10.1080/08860220902963871
  46. Kumar A. Influence of radish consumption on urinary calcium oxalate excretion. Nepal Med Coll J. 2004 Jun;6(1):41–4. https://www.ncbi.nlm.nih.gov/pubmed/15449653
  47. Noronha IL, Andriolo A, Lucon AM, Wroclawski ER, Chade J, Borelli A, et al. [Rice bran in the treatment of idiopathic hypercalciuria in patients with urinary calculosis]. Rev Paul Med. 1989;107(1):19–24.https://europepmc.org/search?query=AUTH:%22Sabbaga+E%22&page=1
  48. Goldfarb DS, Avery AR, Beara-Lasic L, Duncan GE, Goldberg J. A Twin Study of Genetic Influences on Nephrolithiasis in Women and Men. Kidney Int Rep [Internet]. 2019 Apr;4(4):535–40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30993229
  49. Massey LK, Sutton RAL. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol [Internet]. 2004 Aug;172(2):555–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15247728
  50. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998 Apr 1;128(7):534–40. https://www.ncbi.nlm.nih.gov/pubmed/9518397
  51. Saw NK, Chow K, Rao PN, Kavanagh JP. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth. J Urol. 2007 Jun;177(6):2366–70.https://www.ncbi.nlm.nih.gov/pubmed/17509360
  52. Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauzá A, García-Raja A, et al. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion. Scand J Urol Nephrol. 2000 Jun;34(3):162–4.https://www.ncbi.nlm.nih.gov/pubmed/10961468 
  53. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int. 2008 Jan;73(2):207–12.https://www.ncbi.nlm.nih.gov/pubmed/17928824
  54. Lieske JC, de la Vega LSP, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ, et al. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 2006 Dec;48(6):897–904. https://www.ncbi.nlm.nih.gov/pubmed/17162144
  55. Soldati L, Bertoli S, Terranegra A, Brasacchio C, Mingione A, Dogliotti E, et al. Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects. J Transl Med [Internet]. 2014 Feb 6;12:34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24502605
  56. Cheng JW, Wagner H, Asplin JR, Hodgkin G, Schlaifer A, Fargusson M, et al. The Effect of Lemonade and Diet Lemonade Upon Urinary Parameters Affecting Calcium Urinary Stone Formation. J Endourol [Internet]. 2019 Feb;33(2):160–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30585747
  57. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996 Feb 1;143(3):240–7. https://www.ncbi.nlm.nih.gov/pubmed/8561157
  58. Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007 Apr;177(4):1358–62; discussion 1362; quiz 1591.https://www.ncbi.nlm.nih.gov/pubmed/17382731
  59. Aras B, Kalfazade N, Tuğcu V, Kemahli E, Ozbay B, Polat H, et al. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study. Urol Res. 2008 Dec;36(6):313–7. https://www.ncbi.nlm.nih.gov/pubmed/18946667
  60. Buck AC, Davies RL, Harrison T. The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis. J Urol. 1991 Jul;146(1):188–94.https://www.ncbi.nlm.nih.gov/pubmed/2056589
  61. Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis. 2005 Feb;45(2):267–74.https://www.ncbi.nlm.nih.gov/pubmed/15685503
  62. Yasui T, Suzuki S, Itoh Y, Tozawa K, Tokudome S, Kohri K. Eicosapentaenoic Acid Has a Preventive Effect on the Recurrence of Nephrolithiasis. UIN. 2008;81(2):135–8.https://www.karger.com/Article/Abstract/144050
  63. Taylor EN, Curhan GC. Role of nutrition in the formation of calcium-containing kidney stones. Nephron Physiol [Internet]. 2004;98(2):p55-63. https://www.ncbi.nlm.nih.gov/pubmed/15499216
  64. Meschi T, Nouvenne A, Ticinesi A, Prati B, Guerra A, Allegri F, et al. Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med [Internet]. 2012 Mar 28;10:63. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22453026
  65. Chai W, Liebman M, Kynast-Gales S, Massey L. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis [Internet]. 2004 Dec;44(6):1060–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15558527
  66. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and Other Beverages and the Risk of Kidney Stones. CJASN. 2013 Aug 7;8(8):1389–95. https://www.ncbi.nlm.nih.gov/pubmed/23676355
  67. Barilla DE, Townsend J, Pak CY. An exaggerated augmentation of renal calcium excretion after oral glucose ingestion in patients with renal hypercalciuria. Invest Urol. 1978 May;15(6):486–8.https://www.ncbi.nlm.nih.gov/pubmed/348635
  68. Zee T, Bose N, Zee J, Beck JN, Yang S, Parihar J, et al. α-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria. Nat Med [Internet]. 2017 Mar;23(3):288–90. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28165480
  69. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol. 1996 Jun;155(6):1847–51.https://www.ncbi.nlm.nih.gov/pubmed/8618271
  70. Agarwal MM, Singh SK, Mavuduru R, Mandal AK. Preventive fluid and dietary therapy for urolithiasis: An appraisal of strength, controversies and lacunae of current literature. Indian J Urol. 2011;27(3):310–9. http://www.indianjurol.com/article.asp?issn=0970-1591;year=2011;volume=27;issue=3;spage=310;epage=319;aulast=Agarwal
  71. Brenna I, Dogliotti E, Terranegra A, Raspini B, Soldati L. Nephrolithiasis: nutrition as cause or therapeutic tool. J Transl Med [Internet]. 2013 Jul 26;11:178. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23890054
  72. Haleblian GE, Leitao VA, Pierre SA, Robinson MR, Albala DM, Ribeiro AA, et al. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. J Endourol [Internet]. 2008 Jun;22(6):1359–66. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18578663
  73. Nguyen NU, Dumoulin G, Henriet MT, Regnard J. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res. 1995 Mar;27(3):155–8. https://www.ncbi.nlm.nih.gov/pubmed/7607607
  74. Bushinsky DA. Recurrent hypercalciuric nephrolithiasis--does diet help? N Engl J Med [Internet]. 2002 Jan 10;346(2):124–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11784880
  75. Siener R, Hesse A. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr [Internet]. 2003 Dec;42(6):332–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14673606
  76. Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, et al. Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol [Internet]. 2014 Dec;192(6):1694–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24859445
  77. Chae JY, Kim JW, Kim JW, Yoon CY, Park HS, Moon DG, et al. Increased fluid intake and adequate dietary modification may be enough for the successful treatment of uric acid stone. Urolithiasis [Internet]. 2013 Apr;41(2):179–82. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23503881
  78. Rotily M, Léonetti F, Iovanna C, Berthezene P, Dupuy P, Vazi A, et al. Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis. Kidney Int. 2000 Mar;57(3):1115–23. https://www.ncbi.nlm.nih.gov/pubmed/10720964
  79. Marcason W. Where can I find information on the oxalate content of foods? J Am Diet Assoc [Internet]. 2006 Apr;106(4):627–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16567159
  80. Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol. 2008 Sep;3(5):1453–60. https://www.ncbi.nlm.nih.gov/pubmed/18650406
  81. Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Borghi L. Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab. 2008;5(2):135–41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781209/
  82. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S329-333. https://www.ncbi.nlm.nih.gov/pubmed/10541257
  83. Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol. 2011 Apr;25(4):673–9. https://www.ncbi.nlm.nih.gov/pubmed/21381959
  84. D’Alessandro C, Ferraro PM, Cianchi C, Barsotti M, Gambaro G, Cupisti A. Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care. Nutrients [Internet]. 2019 May 27;11(5). Available from: https://www.ncbi.nlm.nih.gov/pubmed/31137803
  85. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral Antibiotic Exposure and Kidney Stone Disease. JASN June 2018, 29 (6) 1731-1740. https://jasn.asnjournals.org/content/29/6/1731
  86. Ivanovski O, Drüeke TB. A new era in the treatment of calcium oxalate stones? Kidney International [Internet]. 2013 Jun 1 ;83(6):998–1000. https://www.kidney-international.org/article/S0085-2538(15)55877-8/fulltext
  87. Borghi L, Meschi T, Maggiore U, Prati B. Dietary therapy in idiopathic nephrolithiasis. Nutr Rev. 2006 Jul;64(7 Pt 1):301–12. https://www.ncbi.nlm.nih.gov/pubmed/16910218
  88. Taylor EN, Fung TT, Curhan GC. DASH-Style Diet Associates with Reduced Risk for Kidney Stones. J Am Soc Nephrol. 2009 Oct;20(10):2253–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754098/
  89. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992 Aug;45(8):911–6. https://www.ncbi.nlm.nih.gov/pubmed/1624973
  90. Odvina CV. Comparative Value of Orange Juice versus Lemonade in Reducing Stone-Forming Risk. CJASN [Internet]. 2006 Nov 1 [cited 2019 Jul 30];1(6):1269–74. Available from: https://cjasn.asnjournals.org/content/1/6/1269
  91. Najem GR, Seebode JJ, Samady AJ, Feuerman M, Friedman L. Stressful life events and risk of symptomatic kidney stones. Int J Epidemiol [Internet]. 1997 Oct;26(5):1017–23. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9363523
  92. Walters DC. Stress as a principal cause of calcium oxalate urolithiasis. International Urology and Nephrology [Internet]. 1986 Sep 1 [cited 2019 Jul 29];18(3):271–5. Available from: https://link.springer.com/article/10.1007/BF02082713
  93. Rydin H, Verney EB. The inhibition of water-diuresis by emotional stress and by muscular exercise. Quarterly Journal of Experimental Physiology [Internet]. 1938 Feb 10 [cited 2019 Jul 29];27(4):343–74. Available from: https://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/expphysiol.1938.sp000757
  94. Corson SA, Corson EOL. Psychosocial influences on renal function—implications for human pathophysiology. In: Levi, L. (ed.): Society, Stress and Disease, Oxford 1971, pp. 338–351.
  95. Brundig P, Berg W, Schneider HJ. [Stress and risk of urolith formation. I. The influence of stress on lithogenous urinary substances (author’s transl)]. Urol Int [Internet]. 1981;36(3):199–207. Available from: https://www.ncbi.nlm.nih.gov/pubmed/7281375
  96. Schmucki O, Asper R, Zortea C. [Stress and urolithiasis]. Urol Int [Internet]. 1984;39(3):159–64. Available from: https://www.ncbi.nlm.nih.gov/pubmed/6740806?dopt=Abstract
  97. Shekarriz B, Lu HF, Stoller ML. Correlation of unilateral urolithiasis with sleep posture. J Urol [Internet]. 2001 Apr;165(4):1085–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11257643
  98. Grases F, Costa-Bauzá A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res [Internet]. 1999 Oct;19(5A):3717–22. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10625946
  99. Schlemmer U, Frølich W, Prieto RM, Grases F. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res [Internet]. 2009 Sep;53 Suppl 2:S330-375. Available from: https://wiebaktmee.nl/cms/pdf/Schlemmer%20_Mol_Nutr_Food_res_2009_Phytate_in_foods_and_significance_for_humans.pdf
  100. Grases F, García-Ferragut L, Costa-Bauzá A. Study of the early stages of renal stone formation: experimental model using urothelium of pig urinary bladder. Urol Res [Internet]. 1996;24(5):305–11. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8931296
  101. Grases F, Garcia-Gonzalez R, Torres JJ, Llobera A. Effects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol [Internet]. 1998 Jul;32(4):261–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9764452
  102. Grases F, Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A. Phytate acts as an inhibitor in formation of renal calculi. Front Biosci [Internet]. 2007 Jan 1;12:2580–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17127264
  103. Conte A, Pizá P, García-Raja A. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate). Arch Esp Urol [Internet]. 1999 Feb;52(1):94–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10101897
  104. Pak CY, Fuller C. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med [Internet]. 1986 Jan;104(1):33–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/3940503
  105. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol [Internet]. 1993 Dec;150(6):1761–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8230497
  106. Whalley NA, Meyers AM, Martins M, Margolius LP. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol [Internet]. 1996 Jul;78(1):10–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8795392
  107. Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, et al. Long-Term Treatment with Potassium Citrate and Renal Stones in Medullary Sponge Kidney. Clin J Am Soc Nephrol [Internet]. 2010 Sep [cited 2019 Jul 29];5(9):1663–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974409/
  108. Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015 Oct 6;(10):CD010057.https://www.ncbi.nlm.nih.gov/pubmed/26439475
  109. Mechlin C, Kalorin C, Asplin J, White M. Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial. J Endourol [Internet]. 2011 Sep;25(9):1541–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21815827
  110. Basiri AH, Taheri FT, Taheri M. STONE DISEASE The Tolerability of Potassium Citrate Tablet in Patients With Intolerance to Potassium Citrate Powder. In 2018. Available from: https://pdfs.semanticscholar.org/dc59/33c9d2aa4c90B9e35befdf382206f6465e2d.pdf?_ga=2.100773705.934826758.1564415236-515772080.1556525906
  111. See Manuel, Chua Michael, Luna Saturnino. 2259 a prospective 6- weeks randomized controlled trial to evaluate the efficacy and safety of sodium bicarbonate, citric acid, sodium citrate, and tartaric acid compound compared to potassium citrate in the treatment of renal stones. Journal of Urology [Internet]. 2012 Apr 1 [cited 2019 Jul 29];187(4S):e911–2. Available from: https://www.auajournals.org/doi/10.1016/j.juro.2012.02.2436
  112. Reddy SVK, Shaik AB, Bokkisam S. Effect of Potassium Magnesium Citrate and Vitamin B-6 Prophylaxis for Recurrent and Multiple Calcium Oxalate and Phosphate Urolithiasis. Korean Journal of Urology [Internet]. 2014 Jun 1 [cited 2019 Jul 29];55(6):411–6. Available from: https://synapse.koreamed.org/DOIx.php?id=10.4111/kju.2014.55.6.411
  113. Hofbauer J, Höbarth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis — a prospective randomized study. British Journal of Urology [Internet]. 1994 [cited 2019 Jul 29];73(4):362–5. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1464-410X.1994.tb07597.x
  114. Lojanapiwat B, Tanthanuch M, Pripathanont C, Ratchanon S, Srinualnad S, Taweemonkongsap T, et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol [Internet]. 2011 Oct;37(5):611–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22099273
  115. Soygür T, Akbay A, Küpeli S. Effect of Potassium Citrate Therapy on Stone Recurrence and Residual Fragments after Shockwave Lithotripsy in Lower Caliceal Calcium Oxalate Urolithiasis: A Randomized Controlled Trial. Journal of Endourology [Internet]. 2002 Apr 1 [cited 2019 Jul 29];16(3):149–52. Available from: https://www.liebertpub.com/doi/10.1089/089277902753716098
  116. Allie-Hamdulay S, Rodgers AL. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial. Urol Res [Internet]. 2005 May 1 [cited 2019 Jul 29];33(2):116–24. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15871014
  117. Ettinger Bruce, Pak Charles Y.C., Citron John T., Thomas Carl, Adams-Huet Beverley, Vangessel Arline. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Journal of Urology [Internet]. 1997 Dec 1 [cited 2019 Jul 29];158(6):2069–73. Available from: https://www.auajournals.org/doi/full/10.1016/S0022-5347%2801%2968155-2
  118. Massey L. Magnesium therapy for nephrolithiasis. Magnes Res [Internet]. 2005 Jun;18(2):123–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16100850
  119. Barbera M, Tsirgiotis A, Barbera M, Paola Q. The importance of citrates in treatment and prophylaxis of calcium oxalate urinary stones. Arch Ital Urol Androl [Internet]. 2016 Dec 30;88(4):343–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28073210
  120. Zerwekh JE, Odvina CV, Wuermser L-A, Pak CYC. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol [Internet]. 2007 Jun;177(6):2179–84. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17509313
  121. Odvina CV, Mason RP, Pak CYC. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Am J Ther [Internet]. 2006 Apr;13(2):101–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16645424
  122. Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, et al. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. J Med Assoc Thai [Internet]. 2004 Mar;87(3):255–63. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15117041
  123. Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, et al. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology [Internet]. 2004 Jan;63(1):7–11; discussion 11-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14751336
  124. Wuermser LA, Reilly C, Poindexter JR, Sakhaee K, Pak CY. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia. Kidney Int [Internet]. 2000 Feb;57(2):607–12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10652038
  125. Ruml LA, Gonzalez G, Taylor R, Wuermser LA, Pak CY. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am J Ther [Internet]. 1999 Jan;6(1):45–50. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10423646
  126. Pak CY, Koenig K, Khan R, Haynes S, Padalino P. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res [Internet]. 1992 Mar;7(3):281–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/1585829
  127. Lindberg J, Harvey J, Pak CY. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol [Internet]. 1990 Feb;143(2):248–51. Available from: https://www.ncbi.nlm.nih.gov/pubmed/2299712
  128. PENNISTON KL, NAKADA SY, HOLMES RP, ASSIMOS DG. Quantitative Assessment of Citric Acid in Lemon Juice, Lime Juice, and Commercially-Available Fruit Juice Products. J Endourol [Internet]. 2008 Mar [cited 2019 Jul 30];22(3):567–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637791/
  129. Arcidiacono T, Terranegra A, Biasion R, Soldati L, Vezzoli G. [Calcium kidney stones. Diagnostic and preventive prospects]. G Ital Nefrol. 2007 Dec;24(6):535–46. https://www.ncbi.nlm.nih.gov/pubmed/18278757
  130. Dogliotti E, Vezzoli G, Nouvenne A, Meschi T, Terranegra A, Mingione A, et al. Nutrition in calcium nephrolithiasis. J Transl Med [Internet]. 2013 May 1;11:109. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23634702
  131. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988 Jan;66(1):140–6. https://www.ncbi.nlm.nih.gov/pubmed/2826524
  132. Calvez J, Poupin N, Chesneau C, Lassale C, Tomé D. Protein intake, calcium balance and health consequences. Eur J Clin Nutr [Internet]. 2012 Mar;66(3):281–95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22127335
  133. Carvalho-Salemi J, Moreno L, Michael M. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part 3: Cystinuria. J Ren Nutr [Internet]. 2017;27(3):e19–21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28411956
  134. Carvalho-Salemi J, Moreno L, Michael M. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part One. J Ren Nutr [Internet]. 2017;27(1):e5–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27979327
  135. Carvalho-Salemi J, Moreno L, Michael M. Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part Two. J Ren Nutr [Internet]. 2017;27(2):e11–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28215360
  136. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004 Mar 11;350(11):1093–103.
  137. De SK, Liu X, Monga M. Changing trends in the American diet and the rising prevalence of kidney stones. Urology [Internet]. 2014 Nov;84(5):1030–3. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25201150
  138. Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN. Physical activity, energy intake and the risk of incident kidney stones. J Urol. 2015 Mar;193(3):864–8. https://www.ncbi.nlm.nih.gov/pubmed/25229560
  139. Ferraro PM, Bonello M, Frigo AC, D’Addessi A, Sturniolo A, Gambaro G. Cadmium exposure and kidney stone formation in the general population--an analysis of the National Health and Nutrition Examination Survey III data. J Endourol [Internet]. 2011 May;25(5):875–80. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21506691
  140. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones. Clin J Am Soc Nephrol [Internet]. 2016 07;11(10):1834–44. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27445166
  141. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women. J Urol [Internet]. 2017;198(4):858–63. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28365271
  142. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013 Apr 2;158(7):535–43. https://www.ncbi.nlm.nih.gov/pubmed/23546565
  143. Flagg LR. Dietary and holistic treatment of recurrent calcium oxalate kidney stones: review of literature to guide patient education. Urol Nurs [Internet]. 2007 Apr;27(2):113–22, 143; quiz 123. https://www.ncbi.nlm.nih.gov/pubmed/17494450 https://www.suna.org/download/education/2009/article04113123.pdf
  144. Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999 Feb;69(2):267–71. https://www.ncbi.nlm.nih.gov/pubmed/9989691
  145. Goldfarb DS. Empiric therapy for kidney stones. Urolithiasis. 2019 Feb;47(1):107–13. https://www.ncbi.nlm.nih.gov/pubmed/30478476
  146. Gul Z, Monga M. Medical and Dietary Therapy for Kidney Stone Prevention. Korean J Urol. 2014 Dec;55(12):775–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710/
  147. Han H, Segal AM, Seifter JL, Dwyer JT. Nutritional Management of Kidney Stones (Nephrolithiasis). Clin Nutr Res [Internet]. 2015 Jul;4(3):137–52. https://www.ncbi.nlm.nih.gov/pubmed/26251832
  148. Heilberg IP. Update on dietary recommendations and medical treatment of renal stone disease. Nephrol Dial Transplant. 2000 Jan 1;15(1):117–23. https://academic.oup.com/ndt/article/15/1/117/1844018
  149. Hess B. Acid-base metabolism: implications for kidney stones formation. Urol Res [Internet]. 2006 Apr;34(2):134–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16411127
  150. Holmes RP, Goodman HO, Hart LJ, Assimos DG. Relationship of protein intake to urinary oxalate and glycolate excretion. Kidney Int. 1993 Aug;44(2):366–72. https://www.ncbi.nlm.nih.gov/pubmed/8377380
  151. Holoch PA, Tracy CR. Antioxidants and self-reported history of kidney stones: the National Health and Nutrition Examination Survey. J Endourol [Internet]. 2011 Dec;25(12):1903–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21864023
  152. Kohn JB. Is medical nutrition therapy appropriate for kidney stones? J Acad Nutr Diet [Internet]. 2014 Sep;114(9):1496. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25169786
  153. Leone A, Fernández-Montero A, de la Fuente-Arrillaga C, Martínez-González MÁ, Bertoli S, Battezzati A, et al. Adherence to the Mediterranean Dietary Pattern and Incidence of Nephrolithiasis in the Seguimiento Universidad de Navarra Follow-up (SUN) Cohort. Am J Kidney Dis [Internet]. 2017 Dec;70(6):778–86. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28838765
  154. Oliveira LMT de, Hauschild DB, Leite C de MBA, Baptista DR, Carvalho M. Adequate dietary intake and nutritional status in patients with nephrolithiasis: new targets and objectives. J Ren Nutr [Internet]. 2014 Nov;24(6):417–22. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25091136
  155. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014 Aug;192(2):316–24. https://www.ncbi.nlm.nih.gov/pubmed/24857648
  156. Penniston KL, Nakada SY. Updates in the Metabolic Management of Calcium Stones. Curr Urol Rep [Internet]. 2018 Apr 16;19(6):41. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29663088
  157. Penniston KL. The nutrition consult for recurrent stone formers. Curr Urol Rep [Internet]. 2015 Jul;16(7):47. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26025494
  158. Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, et al. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl [Internet]. 2015 Jul 7;87(2):105–20. https://www.ncbi.nlm.nih.gov/pubmed/26150027 https://www.pagepressjournals.org/index.php/aiua/article/view/aiua.2015.2.105/4756
  159. Reddy ST, Wang C-Y, Sakhaee K, Brinkley L, Pak CYC. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002 Aug;40(2):265–74. https://www.ncbi.nlm.nih.gov/pubmed/12148098
  160. Robertson WG. Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease. Urolithiasis [Internet]. 2016 Feb;44(1):9–26. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26645870
  161. Saxena A, Sharma RK. Nutritional aspect of nephrolithiasis. Indian J Urol [Internet]. 2010 Oct;26(4):523–30. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21369385
  162. Straub M, Hautmann RE. Developments in stone prevention. Curr Opin Urol. 2005 Mar;15(2):119–26. https://www.ncbi.nlm.nih.gov/m/pubmed/15725936/
  163. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol [Internet]. 2004 Dec;15(12):3225–32. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15579526
  164. Tessaro CZW, Ramos CI, Heilberg IP. Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers. J Bras Nefrol [Internet]. 2018 Mar;40(1):35–43. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29796583
  165. Vezzoli G, Dogliotti E, Terranegra A, Arcidiacono T, Macrina L, Tavecchia M, et al. Dietary style and acid load in an Italian population of calcium kidney stone formers. Nutr Metab Cardiovasc Dis [Internet]. 2015 Jun;25(6):588–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25921845
  166. Yuvanc E, Yilmaz E, Tuglu D, Batislam E. Medical and alternative therapies in urinary tract stone disease. World J Nephrol [Internet]. 2015 Nov 6;4(5):492–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26558186
  167. Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, et al. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014 Mar;63(3):456–63.https://www.ncbi.nlm.nih.gov/pubmed/24560157
  168. Nouvenne A, Ticinesi A, Morelli I, Guida L, Borghi L, Meschi T. Fad diets and their effect on urinary stone formation. Transl Androl Urol. 2014 Sep;3(3):303–12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708571/
  169. Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, Prapaipanich S, Ingsathit A, Rajatanavin R. Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int. 2004 May;65(5):1835–41. https://www.ncbi.nlm.nih.gov/pubmed/15086924
  170. Hess, B., C. Jost, L. Zipperle, R. Takkinen, & P. Jaeger: High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant. 13:2241-2247 (1998)https://www.ncbi.nlm.nih.gov/pubmed/9761503
  171. Lewandowski S, Rodgers A, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int [Internet]. 2001 Mar;87(4):307–11. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11251520
  172. Lieske JC, Tremaine WJ, De Simone C, O’Connor HM, Li X, Bergstralh EJ, et al. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calciumoxalate supersaturation. Kidney Int. 2010 Dec;78(11):1178–85. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923490/
  173. Rodgers AL. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int. 1997;58(2):93–9. https://www.ncbi.nlm.nih.gov/pubmed/9096270
  174. Savage GP, Charrier MJS, Vanhanen L. Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr. 2003 Mar;57(3):415–9. https://www.ncbi.nlm.nih.gov/pubmed/12627177
  175. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015 Apr;67(4):750–63. https://www.ncbi.nlm.nih.gov/pubmed/25454613
  176. Taylor EN, Curhan GC. Dietary Calcium from Dairy and Nondairy Sources, and Risk of Symptomatic Kidney Stones. The Journal of Urology [Internet]. 2013 Oct [cited 2019 Jul 9]; Available from: https://www.auajournals.org/doi/abs/10.1016/j.juro.2013.03.074
  177. Bazyar H, Ahmadi A, Zare Javid A, Irani D, Mohammadi Sartang M, Haghighizadeh MH. The association between dietary intakes and stone formation in patients with urinary stones in Shiraz. Med J Islam Repub Iran [Internet]. 2019;33:8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31086787
  178. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Caffeine intake and the risk of kidney stones. Am J Clin Nutr [Internet]. 2014 Dec;100(6):1596–603. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25411295
  179. Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. J Urol. 2005 Aug;174(2):590–4; quiz 801. https://www.ncbi.nlm.nih.gov/pubmed/16006907
  180. Kessler T, Hesse A. Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Br J Nutr [Internet]. 2000 Dec;84(6):865–71. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11177203
  181. Massey LK, Kynast-Gales SA. Substituting milk for apple juice does not increase kidney stone risk in most normocalciuric adults who form calcium oxalate stones. J Am Diet Assoc [Internet]. 1998 Mar;98(3):303–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9508013
  182. Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010 Mar;91(3):565–70. https://www.ncbi.nlm.nih.gov/pubmed/20042524
  183. Winston D. Herbal and Nutritional Treatment of Kidney Stones. 10(2):11. https://www.americanherbalistsguild.com/files/journal/vol%2010%20no%202/Kidney%20Stones%20V10N2.pdf
  184. Guerra A, Ticinesi A, Allegri F, Nouvenne A, Prati B, Pinelli S, et al. Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: The role of age and sex. Nutrition [Internet]. 2019 Mar;59:83–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30471528
  185. Reinstatler L, Khaleel S, Pais VM. Association of Pregnancy with Stone Formation among Women in the United States: A NHANES Analysis 2007 to 2012. J Urol [Internet]. 2017;198(2):389–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28238670
  186. Robertson WG, Peacock M, Marshall DH. Prevalence of urinary stone disease in vegetarians. Eur Urol. 1982;8(6):334–9. https://www.ncbi.nlm.nih.gov/pubmed/7140784
  187. Fontenelle LF, Sarti TD. Kidney Stones: Treatment and Prevention. Am Fam Physician. 2019 Apr 15;99(8):490-496. https://www.aafp.org/afp/2019/0415/p490.html
  188. Bao Y, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD004292. https://www.ncbi.nlm.nih.gov/pubmed/22696340
  189. Saldana TM, Basso O, Darden R, Sandler DP. Carbonated beverages and chronic kidney disease. Epidemiology. 2007 Jul;18(4):501–6. https://www.ncbi.nlm.nih.gov/pubmed/17525693/
  190. Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009 Jul;56(1):72–80. https://www.ncbi.nlm.nih.gov/pubmed/19321253
  191. Allie S, Rodgers A. Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation. Clin Chem Lab Med. 2003 Jan;41(1):39–45. https://www.ncbi.nlm.nih.gov/pubmed/12636048
  192. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005 Jan;52(1):283–9. https://www.ncbi.nlm.nih.gov/pubmed/15641075
  193. Brulé D, Sarwar G, Savoie L. Changes in serum and urinary uric acid levels in normal human subjects fed purine-rich foods containing different amounts of adenine and hypoxanthine. J Am Coll Nutr. 1992 Jun;11(3):353-8. https://www.ncbi.nlm.nih.gov/pubmed/1619189.
  194. Foundation, The George Mateljan. What are purines and how are they related to food and health? WHfoods.org. http://www.whfoods.com/genpage.php?tname=george&dbid=51.
  195. Baxmann AC, De O G  Mendonça C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int. 2003 Mar;63(3):1066–71. https://www.ncbi.nlm.nih.gov/pubmed/12631089
  196. Chen X, Shen L, Gu X, Dai X, Zhang L, Xu Y, et al. High-dose supplementation with vitamin C--induced pediatric urolithiasis: the first case report in a child and literature review. Urology. 2014 Oct;84(4):922–4. https://www.ncbi.nlm.nih.gov/pubmed/25260453
  197. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J Kidney Dis [Internet]. 2016 Mar;67(3):400–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26463139
  198. Thomas LDK, Elinder C-G, Tiselius H-G, Wolk A, Akesson A. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013 Mar 11;173(5):386–8. https://www.ncbi.nlm.nih.gov/pubmed/23381591
  199. Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP. Ascorbic Acid Intake and Oxalate Synthesis. Urolithiasis. 2016 Aug;44(4):289–97. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946963/
  200. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of Vitamins B6 and C and the Risk of Kidney Stones in Women. JASN. 1999 Apr 1;10(4):840–5. https://jasn.asnjournals.org/content/10/4/840.short
  201. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3704–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39676/
  202. Khan SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res. 2012 Apr;40(2):95–112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683185/

דוגמא לדף מידע מלא

לרכישת מנוי  |  כניסת מנויים

חזרה לתחילת העמוד

חזרה לעמוד הקודם